SCM
GILD icon

Stevens Capital Management’s Gilead Sciences GILD Stock Holding History

Stevens Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46,038
Closed -$5.11M – 255
2025
Q3 		$5.11M Buy
+46,038
New +$5.23M 0.68% 35
2024
Q2 		– Sell
-13,196
Closed -$967K – 273
2024
Q1 		$967K Buy
+13,196
New +$1.01M 0.19% 116
2022
Q2 		– Sell
-14,651
Closed -$871K – 174
2022
Q1 		$871K Buy
+14,651
New +$937K 0.19% 120
2021
Q2 		– Sell
-12,055
Closed -$779K – 204
2021
Q1 		$779K Buy
+12,055
New +$777K 0.43% 43
2020
Q3 		– Sell
-61,626
Closed -$4.74M – 153
2020
Q2 		$4.74M Buy
+61,626
New +$4.72M 1.75% 22
2020
Q1 		– Sell
-41,465
Closed -$2.69M – 174
2019
Q4 		$2.69M Sell
41,465
-67,458
-62% -$4.39M 0.25% 108
2019
Q3 		$6.9M Sell
108,923
-48,795
-31% -$3.19M 0.62% 44
2019
Q2 		$10.7M Sell
157,718
-1,747
-1% -$115K 0.48% 46
2019
Q1 		$10.4M Buy
159,465
+50,892
+47% +$3.38M 0.44% 58
2018
Q4 		$6.79M Buy
+108,573
New +$7.59M 0.35% 79
2017
Q3 		– Sell
-50,931
Closed -$3.6M – 927
2017
Q2 		$3.6M Buy
+50,931
New +$3.39M 0.14% 214
2016
Q1 		– Sell
-198,301
Closed -$20.1M – 968
2015
Q4 		$20.1M Buy
198,301
+144,954
+272% +$15.1M 0.79% 17
2015
Q3 		$5.24M Buy
+53,347
New +$5.92M 0.24% 120
2015
Q2 		– Sell
-111,466
Closed -$10.9M – 1098
2015
Q1 		$10.9M Buy
111,466
+90,619
+435% +$9.2M 0.39% 78
2014
Q4 		$1.97M Sell
20,847
-16,406
-44% -$1.7M 0.07% 299
2014
Q3 		$3.97M Buy
+37,253
New +$3.65M 0.12% 214
2014
Q2 		– Sell
-428,724
Closed -$30.4M – 1141
2014
Q1 		$30.4M Buy
428,724
+319,055
+291% +$25M 0.82% 21
2013
Q4 		$8.24M Buy
+109,669
New +$7.64M 0.24% 111
2013
Q3 		– Sell
-264,761
Closed -$13.6M – 1090
2013
Q2 		$13.6M Buy
+264,761
New +$13.8M 0.45% 48

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Stevens Capital Management's GILD Position: Q4 2025 in Review

Stevens Capital Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 46,038 shares — an estimated $5.11M sold.

Stevens Capital Management first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $30.4M in Q1 2014. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Stevens Capital Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Stevens Capital Management sold 46,038 Gilead Sciences shares in Q4 2025, an estimated $5.11M.
  • Stevens Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
  • Stevens Capital Management's Gilead Sciences position peaked at $30.4M in Q1 2014.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Stevens Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.